About Atherectomy Devices
Atherectomy is a process which is performed to remove atherosclerotic plaque from diseased arteries. Atherosclerotic plates are limited in either coronary or peripheral arterial vasculature and may have different features depending on the quality of the plaque. Atherectomy devices has been used efficiently in treatment of both coronary and peripheral arterial disease. Atherectomy devices are designed differently to either cut, shave or vaporize these plaques and have different indications.
Attributes | Details |
---|
Study Period | 2020-2032 |
Base Year | 2024 |
High Growth Market | North America |
Unit | Value (USD Million) |
CAGR | 6.2% |
Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Atherectomy Devices market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Boston Scientific Corporation (United States), Avinger, Inc. (United States), Cardiovascular Systems, Inc. (United States), Medtronic (Ireland), Royal Philips (Netherlands), Straub Medical (Switzerland), B. Braun Group (Germany), Abbott Laboratories (United States), Terumo Corporation (Japan) and Biomerics (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are C.R. Bard (United States) and BIOTRONIK (Netherlands).
Segmentation Overview
AMA Research has segmented the market of Global Atherectomy Devices market by Type (Rotational Atherectomy, Pathway Jetstream PV Atherectomy System, Excimer Laser Atherectomy, Orbital Atherectomy, Silverhawk Plaque Excision System and Others), Application (Peripheral Vascular, Cardiovascular and Neurovascular) and Region.
On the basis of geography, the market of Atherectomy Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Asia Pacific region held largest market share in the year 2024. If we see Market by End-User, the sub-segment i.e. Hospitals will boost the Atherectomy Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Increasing Incidence of Vascular Diseases and Disorders Related To Calcified Peripheral and Continuous Product Development and Commercialization
Market Growth Drivers:
Rising Number of Patients Suffering from Arthrosclerosis, Diabetes and Obesity
Challenges:
High Cost related to Atherectomy Devices
Restraints:
Lack of Quality Professionals and Limited Patient Awareness Related to Disease Diagnosis
Opportunities:
Infrastructural Development in Developing Regions and Increasing Demand for Vascular and Coronary Intervention
Market Leaders and their expansionary development strategies
On June 11, 2019 - Boston Scientific Corporation has announced that it has closed its acquisition of Vertiflex, Inc., a privately-held company that developed and commercialized the Superion Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS) the narrowing of the spinal canal, which can cause compression of nearby nerves. and On June 27, 2019 - Medtronic plc, a global leader in medical technology, announced it has completed the acquisition of Titan Spine, a privately-held titanium spine interbody implant and surface technology company. Titan Spine pioneered and leads the category of surface-enhanced titanium interbody implants with its unique nanoLOCK platform.
In 2021, Royal Philips launches peripheral and coronary applications in North America, including the Nexcimer laser system. The Nexcimer laser system can be used for peripheral and coronary atherectomy and lead extraction procedures., In 2021, Cardiovascular Systems Inc. is CE Marked for the Diamondback 360 Coronary Orbital Atherectomy System (OAS), which combines pulsatile force with differential sanding to treat all calcium therapies, including nodular, eccentric (irregular) and concentric (ring-shaped). and On April 10, 2019 - Avinger, Inc., a leading developer of image-guided, catheter-based systems for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD) has announced that the Company received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Pantheris SV (Small Vessel) image-guided atherectomy system.
Key Target Audience
Manufacturers of Atherectomy Devices, Suppliers of Atherectomy Devices, Wholesalers, Distributors and Retailers of Atherectomy Devices, Healthcare Industry, Research Organization and Governmental Bodies
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.